Coverage Reiterated: Acadia (ACAD), Alibaba Group (BABA), Ocera Therapeutics (OCRX), Intel (INTC), Du Pont (DD)

Acadia Pharmaceuticals Inc. (ACAD) was reiterated a ‘Buy’ by Jefferies analysts on Thursday. The broker also cut its price target on the stock to $47 from $50. ACAD shares recently lost 9.39 to $35.37. In the past 52 weeks, shares of San Diego, California-based biopharmaceutical company have traded between a low of $15.64 and a […] View the full post at: Coverage Reiterated: Acadia (ACAD), Alibaba Group (BABA), Ocera Therapeutics (OCRX), Intel (INTC), Du Pont (DD) Related posts: Insider Selling: Twitter (TWTR) CEO Unloads $5M Worth of Stock